Expression of LAG-3 on B-lymphocytes as a marker for prediction of response to therapy in patients with chronic lymphocytic leukemia | Selyutina | Siberian journal of oncology

Siberian journal of oncology
Sibirskij onkologičeskij žurnal

ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)

eng | рус

Preview

Siberian journal of oncology

Advanced search

Archives

Download this PDF file

For citations:

Selyutina O.N., Lysenko I.B., Guskova N.K., Novikova I.A., Zlatnik E.Yu., Pushkareva T.F., Nikolaeva N.V., Kamaeva I.A., Samaneva N.Yu., Kapuza E.A. Expression of LAG-3 on B-lymphocytes as a marker for prediction of response to therapy in patients with chronic lymphocytic leukemia. Siberian journal of oncology. 2023;22(2):34-42. (In Russ.) https://doi.org/10.21294/1814-4861-2023-22-2-34-42

Views PDF (Rus): 338

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)

Editor-in-Chief

Evgeny L. Choynzonov

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Notifications

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

O. N. Selyutina
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Olesya N. Selyutina, Biologist, Clinical and Diagnostic Laboratory,

63, 14-th Liniya St., 344037, Rostov-on-Don

I. B. Lysenko
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Irina B. Lysenko, MD, Professor, Head of the Department of Hematology/Oncology,

63, 14-th Liniya St., 344037, Rostov-on-Don

N. K. Guskova
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Nailya K. Guskova, PhD, Head of Clinical and Diagnostic Laboratory,

63, 14-th Liniya St., 344037, Rostov-on-Don

I. A. Novikova
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Inna A. Novikova, MD, PhD, Deputy General Director for Science,

63, 14-th Liniya St., 344037, Rostov-on-Don

E. Yu. Zlatnik
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Elena Yu. Zlatnik, MD, Professor, Chief Researcher of Laboratory of Immunophenotyping of Tumors,

63, 14-th Liniya St., 344037, Rostov-on-Don

T. F. Pushkareva
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Tatyana F. Pushkareva, MD, Oncologist, Clinical Diagnostic Department,

63, 14-th Liniya St., 344037, Rostov-on-Don

N. V. Nikolaeva
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Nadezhda V. Nikolaeva, MD, DSc, Hematologist, Department of Oncology/Hematology, Leading Researcher, Department of Drug Treatment of Tumors,

63, 14-th Liniya St., 344037, Rostov-on-Don

I. A. Kamaeva
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Inna A. Kamaeva, MD, PhD, Junior Researcher, Department of Drug Treatment of Tumors,

63, 14-th Liniya St., 344037, Rostov-on-Don

N. Yu. Samaneva
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Natalya Yu. Samaneva, MD, PhD, Junior Researcher, Department of Drug Treatment of Tumors, Oncologist, Department of Oncology/Hematology,

63, 14-th Liniya St., 344037, Rostov-on-Don

E. A. Kapuza
National Medical Research Institute of Oncology of the Ministry of Health of the Russia
Russian Federation

Elena A. Kapuza, MD, Oncologist, Department of Oncology/Hematology,

63, 14-th Liniya St., 344037, Rostov-on-Don